Successfully advancing your research

Management Team

Director, and Chairman of The Board

John E. Allen, Jr.

A General Partner of Coddle Creek Capital a boutique venture capital and business consulting firm engaged primarily with privately held, early-stage companies providing organizational design, Continue reading

Chief Business Officer

Julian Abery, MSc

A highly experienced sales, marketing and business development professional with a strong track record of formulating a vision, building, leading and motivating multi-disciplinary teams for the development and successful commercialization... Continue reading

Chief Scientific Officer

Julien Curaba, PhD

Julien Curaba, has a PhD from France, with a degree in Molecular and Cellular Biology. He has over 13 years of research experience, with a focus on understanding the mechanisms of transcriptional and post-transcriptional gene regulations. Continue reading

Chief Financial Officer

Brian Smith

Brian began his career in the 80’s as the General Accountant for a government contractor, where he automated the accounting departments’ processes saving hundreds of hours of overtime each year. Continue reading

Operations Director

Becky Borst

Becky Borst has over two decades of extensive management experience. She has a background in the research industry spanning 8 years, and held various management roles in Accounting, Procurement, Building Operations, and Executive Administration. Continue reading

Board of Directors

John E. Allen, Jr.
John E. Allen, Jr.
Leah Allen
Leah Allen
Bill Graham
Bill Graham
David Helmer
David Helmer
Jon Kleu
Jon Kleu

Investors

Coddle Creek Capital

Coddle Creek Capital

Coddle Creek Capital is a life science venture capital fund centered on developing, fostering, and propagating a regional ecosystem that continues beyond the length of the fund investments. The organization focuses on commercializing innovations i... Continue reading

Looking for deeper insights on your next project? Discuss a project
"Eremid provides the support we need to make a global impact in our large immunogenomic oncology clinical studies. The team’s expertise and flexibility from assay design to data delivery is helping us achieve our vision – an ideal research partner." Geoffrey Erickson, Immunis AI, MI USA — Senior Vice President, Corporate Development
"Working with Eremid has been a pleasure. We received excellent data with a very fast turnaround and appreciated the attentive and helpful project management!" Steve Watkins, BCD Biosciences, CA USA — CEO
Trusted by